Briefs

Novartis to Investigate Second Death in Gene Therapy Trials

April 29, 2019

Despite positive interim trial results for its experimental gene therapy for spinal muscular atrophy in infants, Novartis AG announced last week it will investigate a second trial death that may be related to the same treatment.